null

Emapalumab (Anti-IFNG) Biosimilar Antibody

SKU:
HDBS0128
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
IFNG
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
€373
Frequently bought together:

Description

system_update_altDatasheet

Emapalumab (Anti-IFNG) Biosimilar Antibody (HDBS0128)

The Emapalumab Biosimilar Anti-IFNγ Antibody is a cutting-edge product designed for research involving the immune system and inflammatory conditions. This monoclonal antibody, derived from a biosimilar of Emapalumab, specifically targets and inhibits the activity of IFNγ, a key cytokine involved in regulating immune responses.This antibody is highly specific and sensitive, making it an excellent tool for studying the role of IFNγ in various cellular processes, including immune cell activation, inflammation, and host defense mechanisms. Its validation for use in various research applications, such as ELISA and immunohistochemistry, ensures reliable and reproducible results in your studies.

The Emapalumab Biosimilar Anti-IFNγ Antibody offers researchers the opportunity to delve into the intricate mechanisms of immune regulation and explore potential therapeutic strategies for diseases characterized by dysregulated IFNγ signaling, such as autoimmune disorders, infectious diseases, and cancer. By targeting IFNγ with this innovative antibody, researchers can gain valuable insights into the complex interplay between the immune system and disease pathology.